Question 1

What is Kymera Therapeutics's total operating expenses?

Accepted Answer

Kymera Therapeutics (KYMR) reported total operating expenses of $140.61M in Q2 2026.

Question 2

How has Kymera Therapeutics's total operating expenses changed year-over-year?

Accepted Answer

Kymera Therapeutics's total operating expenses increased by 46.4% year-over-year, from $96.03M to $140.61M.

Question 3

What is the long-term trend for Kymera Therapeutics's total operating expenses?

Accepted Answer

Over 4 years (2021 to 2025), Kymera Therapeutics's total operating expenses has grown at a 22.4% compound annual growth rate (CAGR), from $173.36M to $388.61M.

Question 4

What does total operating expenses mean?

Accepted Answer

The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.

Line item	Three Months Ended June 30, 2026	Three Months Ended June 30, 2025	Six Months Ended June 30, 2026	Six Months Ended June 30, 2025
Operating expenses:
Research and development	$119,481	$78,388	$217,644	$158,643
General and administrative	21,126	17,645	41,484	33,916
Total operating expenses	140,607	96,033	259,128	192,559
Loss from operations	(75,607)	(84,557)	(159,763)	(158,983)
Other income (expense):
Interest and other income	14,477	8,051	29,459	16,968
Interest and other expense	(81)	(108)	(141)	(180)

Total Operating Expenses at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about Kymera Therapeutics's total operating expenses.

Kymera Therapeutics KYMR Total Operating Expenses